Qrativ Company
Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
Founded Date:
2017-01-01
Last Funding Type:
Series A
Headquarters:
Cambridge, Massachusetts, United States
Investors Number:
3.0
Technology:
['BioTech & HealthTech']
Employee Number:
11-50
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-07-14
Funding Status:
Early Stage Venture
Total Funding:
8300000.0